Anthony Pius Shen Acquires 7,000 Shares of Vitalhub (TSE:VHI) Stock

Key Points

• Director Anthony Pius Shen purchased 7,000 shares on March 30 at an average price of C$7.11 (total C$49,770), raising his holdings to 12,470 shares — a 127.97% increase in ownership.
• Vitalhub (TSE:VHI) traded at C$6.87 that day, below its 50-day (C$8.07) and 200-day (C$9.29) moving averages, with a market cap of C$434.4 million and a 1-year range of C$6.67–C$14.64.
• Analysts maintain a consensus "Buy" rating with a consensus target of C$13.86, although several firms recently trimmed their price targets while keeping mostly Outperform/Buy ratings.

Vitalhub Corp. (TSE:VHI - Get Free Report) Director Anthony Pius Shen bought 7,000 shares of the company's stock in a transaction that occurred on Monday, March 30th. The shares were bought at an average cost of C$7.11 per share, for a total transaction of C$49,770.00. Following the completion of the acquisition, the director owned 12,470 shares of the company's stock, valued at C$88,661.70. This trade represents a 127.97% increase in their ownership of the stock.

Vitalhub Price Performance

TSE:VHI traded down C$0.08 during trading hours on Monday, reaching C$6.87. The company had a trading volume of 273,982 shares, compared to its average volume of 359,123. The firm has a market cap of C$434.40 million, a PE ratio of 68.70, a price-to-earnings-growth ratio of 1.18 and a beta of 0.65. Vitalhub Corp. has a 1-year low of C$6.67 and a 1-year high of C$14.64. The business's 50 day moving average price is C$8.07 and its 200-day moving average price is C$9.29.

Vitalhub (TSE:VHI - Get Free Report) last posted its earnings results on Wednesday, March 18th. The company reported C$0.06 earnings per share for the quarter. Vitalhub had a net margin of 5.61% and a return on equity of 2.75%. The firm had revenue of C$31.39 million during the quarter. On average, analysts expect that Vitalhub Corp. will post 0.2296467 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

Several equities research analysts have recently issued reports on the stock. Royal Bank Of Canada lowered their target price on shares of Vitalhub from C$13.00 to C$12.00 and set an "outperform" rating on the stock in a research note on Monday, January 26th. Raymond James Financial lowered their price target on Vitalhub from C$15.00 to C$11.00 and set an "outperform" rating on the stock in a research report on Tuesday, March 24th. ATB Cormark Capital Markets dropped their price objective on Vitalhub from C$16.50 to C$15.00 and set an "outperform" rating on the stock in a report on Tuesday, March 10th. Finally, Scotiabank reduced their target price on Vitalhub from C$15.00 to C$12.00 and set an "outperform" rating for the company in a research note on Wednesday, February 4th. One investment analyst has rated the stock with a Strong Buy rating and six have given a Buy rating to the stock. According to data from MarketBeat, Vitalhub has a consensus rating of "Buy" and a consensus target price of C$13.86.

About Vitalhub

Vitalhub Corp is Canada-based firm that develops technology solutions for health and human services providers in the mental health (child through adult), long term care, community health service, home health, social service, and acute care sectors. Its technologies include blockchain, mobile, patient flow, web-based assessment, and electronic health record solutions.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.